No overt deficits in aged tau-deficient C57Bl/6.Mapttm1(EGFP)kit GFP knockin mice

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Van Hummel, Annika ^a   Bi, Mian ^a   Ippati, Stefania ^a   Van Der Hoven, Julia ^a   Volkerling, Alexander ^a   Lee, Wei S ^a   Tan, Daniel C S ^a   Bongers, Andre ^a   Ittner, Arne ^a   Ke, Yazi D ^a   Ittner, Lars M ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; TAU PROTEIN; MAPT PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; FEMALE; FUNCTIONAL DISEASE; GENETIC BACKGROUND; HETEROZYGOSITY; HOMOZYGOSITY; IMAGE ANALYSIS; KNOCKOUT MOUSE; MALE; MAPT GENE; MEMORY TEST; MOTOR FUNCTION TEST; MOUSE; NONHUMAN; OB/OB MOUSE; PROTEIN DEFICIENCY; PROTEIN DEPLETION; SUBSTANTIA NIGRA; WILD TYPE MOUSE; ALZHEIMER DISEASE; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; GENE INACTIVATION; GENE TARGETING; GENETICS; LOCOMOTION; MAZE TEST; MEMORY; METABOLISM; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCK-IN TECHNIQUES; GENE KNOCKOUT TECHNIQUES; GREEN FLUORESCENT PROTEINS; LOCOMOTION; MALE; MAZE LEARNING; MEMORY; MICE, INBRED C57BL; MICE, TRANSGENIC; TAU PROTEINS;

EID: 84991461460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163236     Document Type: Article

References (28)

1. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995; 16(3):271-8; discussion 8-84. Epub 1995/05/01. 0197458095000216 [pii]. PMID: 7566337.
2. Ke YD, Suchowerska AK, van der Hoven J, De Silva DM, Wu CW, van Eersel J, et al. Lessons from tau-deficient mice. International journal of Alzheimer's disease. 2012; 2012:873270. Epub 2012/06/22. doi: 10.1155/2012/873270 PMID: 22720190; PubMed Central PMCID: PMC3375147.
3. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic Function of Tau Mediates Amyloid-beta Toxicity in Alzheimer's Disease Mouse Models. Cell. 2010; 142(3):387-97. Epub 2010/07/27. S0092-8674(10)00726-9 [pii] doi: 10.1016/j.cell.2010.06.036 PMID: 20655099.
4. Gotz J, Ittner LM, Kins S. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? J Neurochem. 2006; 98(4):993-1006. PMID: 16787410. doi: 10.1111/j.1471-4159.2006.03955.x
5. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, et al. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature. 1994; 369(6480):488-91. PMID: 8202139. doi: 10.1038/369488a0
6. Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci. 2001; 114(Pt 6):1179-87. PMID: 11228161.
7. Tucker KL, Meyer M, Barde YA. Neurotrophins are required for nerve growth during development. Nat Neurosci. 2001; 4(1):29-37. PMID: 11135642. doi: 10.1038/82868
8. Fujio K, Sato M, Uemura T, Sato T, Sato-Harada R, Harada A. 14-3-3 proteins and protein phosphatases are not reduced in tau-deficient mice. Neuroreport. 2007; 18(10):1049-52. Epub 2007/06/15. doi: 10.1097/WNR.0b013e32818b2a0b PMID: 17558294.
9. Takei Y, Teng J, Harada A, Hirokawa N. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol. 2000; 150(5):989-1000. Epub 2000/09/07. PMID: 10973990; PubMed Central PMCID: PMC2175245.
10. Ikegami S, Harada A, Hirokawa N. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci Lett. 2000; 279(3):129-32. Epub 2000/02/25. PMID: 10688046.
11. Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med. 2012; 18(2):291-5. Epub 2012/01/31. doi: 10.1038/nm.2613 PMID: 22286308.
12. Morris M, Hamto P, Adame A, Devidze N, Masliah E, Mucke L. Age-appropriate cognition and subtle dopamine-independent motor deficits in aged tau knockout mice. Neurobiol Aging. 2013; 34(6):1523-9. doi: 10.1016/j.neurobiolaging.2012.12.003 PMID: 23332171; PubMed Central PMCID: PMCPMC3596503.
13. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science. 2007; 316(5825):750-4. PMID: 17478722. doi: 10.1126/science.1141736
14. Ma QL, Zuo X, Yang F, Ubeda OJ, Gant DJ, Alaverdyan M, et al. Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging. J Neurosci. 2014; 34(21):7124-36. doi: 10.1523/JNEUROSCI.3439-13.2014 PMID: 24849348; PubMed Central PMCID: PMCPMC4028492.
15. van Eersel J, Ke YD, Liu X, Delerue F, Kril JJ, Gotz J, et al. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc Natl Acad Sci U S A. 2010; 107(31):13888-93. Epub 2010/07/21. 1009038107 [pii] doi: 10.1073/pnas.1009038107 PMID: 20643941.
16. Ke YD, van Hummel A, Stevens CH, Gladbach A, Ippati S, Bi M, et al. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathol. 2015; 130(5):661-78. doi: 10.1007/s00401-015-1486-0 PMID: 26437864.
17. van Eersel J, Stevens CH, Przybyla M, Gladbach A, Stefanoska K, Chan CK, et al. Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration. Neuropathology and applied neurobiology. 2015; 41(7):906-25. doi: 10.1111/nan.12233 PMID: 25763777.
18. Langkammer C, Krebs N, Goessler W, Scheurer E, Ebner F, Yen K, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology. 2010; 257(2):455-62. doi: 10.1148/radiol.10100495 PMID: 20843991.
19. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005; 23(1):1-25. doi: 10.1016/j.mri.2004.10.001 PMID: 15733784.
20. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec. 1991; 231(4):482-97. doi: 10.1002/ar.1092310411 PMID: 1793176.
21. Ittner LM, Ke YD, Gotz J. Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease. J Biol Chem. 2009; 284(31):20909-16. Epub 2009/06/06. M109.014472 [pii] doi: 10.1074/jbc.M109.014472 PMID: 19491104.
22. Dawson HN, Cantillana V, Jansen M, Wang H, Vitek MP, Wilcock DM, et al. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease. Neuroscience. 2010; 169(1):516-31. Epub 2010/05/04. S0306-4522(10)00580-4 [pii] doi: 10.1016/j.neuroscience.2010.04.037 PMID: 20434528; PubMed Central PMCID: PMC2900546.
23. Ahmed T, Van der Jeugd A, Blum D, Galas MC, D'Hooge R, Buee L, et al. Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion. Neurobiol Aging. 2014; 35(11):2474-8. doi: 10.1016/j.neurobiolaging.2014.05.005 PMID: 24913895.
24. Lei P, Ayton S, Moon S, Zhang Q, Volitakis I, Finkelstein DI, et al. Motor and cognitive deficits in aged tau knockout mice in two background strains. Mol Neurodegener. 2014; 9:29. doi: 10.1186/1750-1326-9-29 PMID: 25124182; PubMed Central PMCID: PMCPMC4141346.
25. Cantero JL, Moreno-Lopez B, Portillo F, Rubio A, Hita-Yanez E, Avila J. Role of tau protein on neocortical and hippocampal oscillatory patterns. Hippocampus. 2011; 21(8):827-34. Epub 2010/07/08. doi: 10.1002/hipo.20798 PMID: 20607795.
26. Morris M, Koyama A, Masliah E, Mucke L. Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease. PLoS One. 2011; 6(12):e29257. Epub 2011/12/30. doi: 10.1371/journal.pone.0029257 PMID: 22206005; PubMed Central PMCID: PMC3242771.
27. Li Z, Hall AM, Kelinske M, Roberson ED. Seizure resistance without parkinsonism in aged mice after tau reduction. Neurobiol Aging. 2014; 35(11):2617-24. doi: 10.1016/j.neurobiolaging.2014.05.001 PMID: 24908165; PubMed Central PMCID: PMCPMC4171213.
28. Lopes S, Lopes A, Pinto V, Guimaraes MR, Sardinha VM, Duarte-Silva S, et al. Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment. Aging Cell. 2016; 15(2):208-16. doi: 10.1111/acel.12391 PMID: 26748966; PubMed Central PMCID: PMCPMC4783352.